US Stock MarketDetailed Quotes

INSP Inspire Medical Systems

Watchlist
  • 179.360
  • -3.930-2.14%
Close Mar 10 16:00 ET
  • 181.000
  • +1.640+0.91%
Pre 07:56 ET
5.32BMarket Cap102.49P/E (TTM)

Inspire Medical Systems Key Stats

Inspire Medical Systems Q4 2024 Earnings Date

Currency:USDFeb 10, 2025

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
237.41M
239.72M
+2.31M
Beat Est.
+23.32%
+24.52%
+0.97%
EPS
0.72
1.15
+0.43
Beat Est.
+46.53%
+134.69%
+60.17%
Strong Buy

Mar 10, 2025

Inspire Medical Systems Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 16 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 227.725M--
--2025/Q1-- / 194.894M--
Feb 10, 20252024/Q4239.718M / 237.408M--
Nov 4, 20242024/Q3203.191M / 197.588M--
Aug 6, 20242024/Q2195.885M / 195.900M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 227.725M--
--2025/Q1-- / 194.894M--
Feb 10, 20252024/Q4239.718M / 237.408M--
Nov 4, 20242024/Q3203.191M / 197.588M--
Aug 6, 20242024/Q2195.885M / 195.900M--

Unlock Free Earnings Estimates

Inspire Medical Systems Earnings Reports

Read more

Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Mar 10, 2025

Strong Buy

  • Buy

    76.47%
  • Hold

    23.53%
  • Sell

    0.00%

Price Target

No Data